Prevalence of oral anticoagulant therapy in clinical practice in patients hospitalized with acute ischemic stroke

Aim. To evaluate the prevalence of oral anticoagulant therapy at the outpatient and inpatient stages in patients hospitalized with ischemic stroke.Material and methods. This open observational prospective real-world study included 114 patients with atrial fibrillation (AF) hospitalized with confirme...

Full description

Saved in:
Bibliographic Details
Main Authors: E. V. Tavlueva, O. N. Savkova, E. V. Zernova, S. A. Berns, O. M. Drapkina
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2023-01-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/5149
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849341423620456448
author E. V. Tavlueva
O. N. Savkova
E. V. Zernova
S. A. Berns
O. M. Drapkina
author_facet E. V. Tavlueva
O. N. Savkova
E. V. Zernova
S. A. Berns
O. M. Drapkina
author_sort E. V. Tavlueva
collection DOAJ
description Aim. To evaluate the prevalence of oral anticoagulant therapy at the outpatient and inpatient stages in patients hospitalized with ischemic stroke.Material and methods. This open observational prospective real-world study included 114 patients with atrial fibrillation (AF) hospitalized with confirmed stroke.Results. Only 26,3% of patients with AF hospitalized with a confirmed diagnosis of ischemic stroke took anticoagulants (70% — direct oral anticoagulants (DOACs), 30% — warfarin). At the same time, among those taking warfarin, only one patient had normal international normalized ratio (INR) at the time of hospitalization (INR 2,6). In all other cases, the INR was <2. Of the 105 patients discharged at the outpatient stage, 93 (88,6%) patients were prescribed anticoagulants, and in most cases — DOACs (89 (84,8%)). 4 (3,8%) patients insisted on continuing warfarin therapy. There were following reasons for not prescribing DOACs: 4 (33,3%) patients were diagnosed with acute peptic ulcer during hospitalization, 2 (16,7%) — hemorrhagic transformation of the ischemic focus.Conclusion. One of the common reasons for stroke in outpatients with AF is the refusal to take oral anticoagulants or insufficient INR control when taking warfarin.
format Article
id doaj-art-5fc73e66222b4983b8ae364fd42a5dba
institution Kabale University
issn 1560-4071
2618-7620
language Russian
publishDate 2023-01-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj-art-5fc73e66222b4983b8ae364fd42a5dba2025-08-20T03:43:37Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202023-01-01271210.15829/1560-4071-2022-51493718Prevalence of oral anticoagulant therapy in clinical practice in patients hospitalized with acute ischemic strokeE. V. Tavlueva0O. N. Savkova1E. V. Zernova2S. A. Berns3O. M. Drapkina4F.I. Inozemtsev City Clinical Hospital; National Medical Research Center for Therapy and Preventive MedicineF.I. Inozemtsev City Clinical HospitalF.I. Inozemtsev City Clinical HospitalNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineAim. To evaluate the prevalence of oral anticoagulant therapy at the outpatient and inpatient stages in patients hospitalized with ischemic stroke.Material and methods. This open observational prospective real-world study included 114 patients with atrial fibrillation (AF) hospitalized with confirmed stroke.Results. Only 26,3% of patients with AF hospitalized with a confirmed diagnosis of ischemic stroke took anticoagulants (70% — direct oral anticoagulants (DOACs), 30% — warfarin). At the same time, among those taking warfarin, only one patient had normal international normalized ratio (INR) at the time of hospitalization (INR 2,6). In all other cases, the INR was <2. Of the 105 patients discharged at the outpatient stage, 93 (88,6%) patients were prescribed anticoagulants, and in most cases — DOACs (89 (84,8%)). 4 (3,8%) patients insisted on continuing warfarin therapy. There were following reasons for not prescribing DOACs: 4 (33,3%) patients were diagnosed with acute peptic ulcer during hospitalization, 2 (16,7%) — hemorrhagic transformation of the ischemic focus.Conclusion. One of the common reasons for stroke in outpatients with AF is the refusal to take oral anticoagulants or insufficient INR control when taking warfarin.https://russjcardiol.elpub.ru/jour/article/view/5149atrial fibrillationstrokeanticoagulants
spellingShingle E. V. Tavlueva
O. N. Savkova
E. V. Zernova
S. A. Berns
O. M. Drapkina
Prevalence of oral anticoagulant therapy in clinical practice in patients hospitalized with acute ischemic stroke
Российский кардиологический журнал
atrial fibrillation
stroke
anticoagulants
title Prevalence of oral anticoagulant therapy in clinical practice in patients hospitalized with acute ischemic stroke
title_full Prevalence of oral anticoagulant therapy in clinical practice in patients hospitalized with acute ischemic stroke
title_fullStr Prevalence of oral anticoagulant therapy in clinical practice in patients hospitalized with acute ischemic stroke
title_full_unstemmed Prevalence of oral anticoagulant therapy in clinical practice in patients hospitalized with acute ischemic stroke
title_short Prevalence of oral anticoagulant therapy in clinical practice in patients hospitalized with acute ischemic stroke
title_sort prevalence of oral anticoagulant therapy in clinical practice in patients hospitalized with acute ischemic stroke
topic atrial fibrillation
stroke
anticoagulants
url https://russjcardiol.elpub.ru/jour/article/view/5149
work_keys_str_mv AT evtavlueva prevalenceoforalanticoagulanttherapyinclinicalpracticeinpatientshospitalizedwithacuteischemicstroke
AT onsavkova prevalenceoforalanticoagulanttherapyinclinicalpracticeinpatientshospitalizedwithacuteischemicstroke
AT evzernova prevalenceoforalanticoagulanttherapyinclinicalpracticeinpatientshospitalizedwithacuteischemicstroke
AT saberns prevalenceoforalanticoagulanttherapyinclinicalpracticeinpatientshospitalizedwithacuteischemicstroke
AT omdrapkina prevalenceoforalanticoagulanttherapyinclinicalpracticeinpatientshospitalizedwithacuteischemicstroke